Rocha Guillermo, Butler Michael, Butler Andrea, Hackett Joanne M
GRMC Vision Centre, Image Plus Laser Eye Centre, University of Manitoba, Winnipeg, Manitoba, Canada ; Department of Ophthalmology, University of Ottawa Eye Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.
Saudi J Ophthalmol. 2011 Jul;25(3):261-7. doi: 10.1016/j.sjopt.2011.04.006. Epub 2011 Apr 30.
To introduce femtosecond laser wound design combined with riboflavin/ultraviolet light-A (UVA) collagen cross-linking at the wound for penetrating (PKP) and anterior lamellar keratoplasty (ALK). Primary outcomes were intraocular pressure (IOP in mmHg) at burst point for the PKP group, and tensile strength (kPa) until dehiscence for the ALK group.
Human corneoscleral rims (N = 20) were mounted on artificial anterior chambers. PKP specimens underwent FUR, femtosecond laser-cut without cross-linking, or conventional corneal transplantation. PKP maximum burst IOP with progressive suture removal was assessed by a digital manometer, in triplicate and by three observers. ALK involved whole human globes (N = 10) divided into three groups using a 200-micron, 8 mm diameter donor lenticule, with or without cross-linking. Cross-linked specimens were exposed to UVA light (3 mW/cm(2) irradiance, 3.4 J, 370 nm wavelength) for 30 min with 0.1% riboflavin (20% Dextran) applied every 2-min. ALK tensile strength was determined using a digital tensiometer.
In PKP, burst IOP was 31.32 mmHg greater for corneas that underwent the UVA-riboflavin treatment than for those that did not (p < 0.05). There was no significant relationship (p = 0.719) established between cut design (femtosecond versus conventional). On multivariate analysis, there was a mean of 15.82 mmHg higher sustainable pressure for each stabilization suture present (p < 0.0001). In ALK, specimens comprised of human donor and human recipient tissue combined with UVA-riboflavin therapy experienced the greatest level of adhesion strength (954.7 ± 290.4 kPa) as shown by the force required to separate the tissues, and compared to non-cross-linked specimens. Electron microscopy of ALK specimens showed non-fused and fused longitudinal cross-linked collagen fibers as well as bridges, densities, attachment plaques and primitive plasmalemmal densities.
Cross-linking effects of the FUR technique enable a stronger graft-recipient adhesion compared to conventional penetrating and anterior lamellar keratoplasty. Electron microscopy enabled visualization of cross-linked interface and potential bonding. The FUR approach may further lead to sutureless transplantation techniques in the future.
SETTING/VENUE: ImagePlus Laser Eye Centre, Winnipeg, and University of Ottawa Eye Institute, Ottawa, Canada.
介绍飞秒激光伤口设计联合核黄素/紫外线A(UVA)胶原交联技术用于穿透性角膜移植术(PKP)和前板层角膜移植术(ALK)的伤口处理。主要观察指标为PKP组破裂点时的眼压(以毫米汞柱为单位),以及ALK组直至裂开时的拉伸强度(以千帕为单位)。
将人角膜缘(n = 20)安装在人工前房上。PKP标本分别接受飞秒激光交联(FUR)、未交联的飞秒激光切割或传统角膜移植。使用数字压力计对PKP标本在逐步拆除缝线过程中的最大破裂眼压进行评估,由三名观察者重复测量三次。ALK涉及完整的人眼球(n = 10),使用直径8毫米、厚度200微米的供体透镜分为三组,分别进行交联或不交联处理。交联标本暴露于UVA光(辐照度3 mW/cm²,波长370 nm,能量3.4 J)下30分钟,每2分钟涂抹一次0.1%核黄素(20%右旋糖酐)。使用数字张力计测定ALK的拉伸强度。
在PKP中,接受UVA - 核黄素处理的角膜破裂眼压比未处理的角膜高31.32毫米汞柱(p < 0.05)。切割设计(飞秒激光与传统方法)之间未建立显著相关性(p = 0.719)。多因素分析显示,每存在一根稳定缝线,可持续眼压平均高出15.82毫米汞柱(p < 0.0001)。在ALK中,由人供体和人受体组织组成并联合UVA - 核黄素治疗的标本,其组织分离所需的力表明具有最高水平的黏附强度(954.7 ± 290.4千帕),与未交联标本相比。ALK标本的电子显微镜检查显示有未融合和融合的纵向交联胶原纤维以及桥、密度、附着斑和原始质膜密度。
与传统的穿透性和前板层角膜移植术相比,FUR技术的交联效果能使移植片与受体之间的黏附更强。电子显微镜检查能够观察到交联界面和潜在的结合情况。FUR方法未来可能会进一步推动无缝线移植技术的发展。
地点/场所:加拿大温尼伯的ImagePlus激光眼科中心和渥太华大学眼科研究所。